Vitrakvi Capsule
Product Images NDC 50419-390
Product Visual Gallery
This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Vitrakvi (NDC 50419-390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Vitrakvi 02)
Chemical Structure (Vitrakvi 03)
Chemical Structure (Vitrakvi 04)
Chemical Structure (Vitrakvi 05)
Chemical Structure (Vitrakvi 06)
Chemical Structure (Vitrakvi 07)
Chemical Structure (Vitrakvi 08)
Chemical Structure (Vitrakvi 09)
Chemical Structure (Vitrakvi 10)
Chemical Structure (Vitrakvi 11)
Chemical Structure (Vitrakvi 12)
Chemical Structure (Vitrakvi 13)
Chemical Structure (Vitrakvi 14)
Chemical Structure (Vitrakvi 15)
Chemical Structure (Vitrakvi 16)
Chemical Structure (Vitrakvi 17)
Chemical Structure (Vitrakvi 18)
Image Of 25 mg Label Principal Panel (60 capsules)
Image Of 100 mg Label Principal Panel (60 capsules)
Image Of 20 mg/ml Label Principal Panel (100 mL oral solution)
Package Label (20 mg/mL)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.